NCOA3 and cancer: CM272 which substantially increased the cancer cell killing effect in combination with SI-12 (Fig. S6), yet it was not toxic to the hepatocytes (Fig. S5j and Table S2), which suggests that DNMT as a atrget should not be ruled out for improved cancer cell killing in combination with SRC-3 inhibition.